logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Incyte Corporation Skyrockets on Promising Trial for Jakafi

  +Follow August 21, 2013 9:20AM
Share:
Tickers Mentioned:

Pharmaceutical company Incyte Corporation (INCY) released very positive news on Aug. 21, revealing that their pancreatic cancer treatment drug ruxolitinib, marketed under the trade name Jakafi, had performed very well in Phase II trials, and that the drug could now move on to Phase III.

Incyte Executive Vice President Richard S. Levy pointed out that sufferers from advanced pancreatic cancer currently have very few options. If approved, the orally-administered drug would be one of the first on the market that exists as "an attractive treatment option" for sufferers of pancreatic cancer.

If approved by the FDA, this would be a major breakthrough. Metastatic pancreatic cancer has the lowest survival rate of any form of cancer. Currently, less than one percent of people afflicted survive more than five years.

Jakafi's ability to increase lifespan for sufferers looks very promising. In the Phase II trials, the six month survival rate for patients (when coupled with chemotherapy treatment) for Jakafi was 42 percent, compared to 11 percent for patients on a placebo.

Jakafi was first approved by the Food and Drug Administration in 2011 to treat a bone marrow disease. After its success in that arena, the company specualted that the drug might effectively treat other types of cancer as well. Now, the drug is fast aproaching approval to treat pancreatic cancer as well. Though it is currently the only drug the company has gotten passed by the USFDA. Jakafi seems to be fulfilling early analyst speculation that it could be a billion dollar blockbuster drug for the Delaware-based drug maker.

Incyte earned $54.1 million from sales of Jakafi in the second quarter of 2013, and expects to earn between $220 and $230 million total this year.

Incyte rocketed on the news, and went up 29.19 percent to hit $34.88 a share. They’re up 58.82 percent on the year.

(image courtesy of Wikimedia commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for INCY
Coffee Club
1 Apr 15 19:00:48
@Takashi8 @Dealreporter would $incy be a better sale
Breaking News Now
1 Apr 15 17:10:02
$INCY: Insider Selling: Reid M. Huber Sells 34263 Shares of Incyte Stock ...: http://t.co/jVz6lW1Z2H
Kristina Duering
1 Apr 15 17:06:07
RT @newswelldone: $INCY: Incyte EVP Reid M. Huber Sells 34263 Shares (INCY): http://t.co/x41hxW1pbv
Breaking News
1 Apr 15 17:00:04
$INCY: Incyte EVP Reid M. Huber Sells 34263 Shares (INCY): http://t.co/x41hxW1pbv
WKRB News
1 Apr 15 16:59:16
Incyte EVP Reid M. Huber Sells 34,263 Shares $INCY http://t.co/NaXMOoynvb
ProVesting
1 Apr 15 16:40:02
$INCY: Insider Selling: Incyte VP Laurent Chardonnet Sells 113776 Shares ...: http://t.co/5jHea7hkyv
Sleek Money
1 Apr 15 16:35:15
Insider Selling: Incyte VP Laurent Chardonnet Sells 113,776 Shares of Stock $INCY http://t.co/hiiGGAa0Jd
The Legacy News
1 Apr 15 16:27:12
Insider Selling: Reid M. Huber Sells 34,263 Shares of Incyte Stock $INCY http://t.co/7fWn77i6AZ
Ticker Report
1 Apr 15 16:26:23
Insider Selling: Reid M. Huber Sells 34,263 Shares of Incyte Stock $INCY http://t.co/7uVirad4yF
Ticker Report
1 Apr 15 16:26:21
Incyte VP Sells $10,653,984.64 in Stock $INCY http://t.co/b8q4eYlvn0
StockNewsWires
1 Apr 15 16:25:02
$INCY: Incyte VP Sells $10653984.64 in Stock (INCY): http://t.co/bPXP7CnA7F
US Banking News
1 Apr 15 16:22:19
Insider Selling: Reid M. Huber Sells 34,263 Shares of Incyte Stock $INCY http://t.co/jMRd18pKJ7
US Banking News
1 Apr 15 16:22:17
Incyte VP Sells $10,653,984.64 in Stock $INCY http://t.co/ykXACa9K3y
Coffee Club
1 Apr 15 15:11:37
@OpenOutcrier what about $incy it's been very quiet on this one. We hear news on $rcpt and $bmrn. Share some love
sunil kumar
1 Apr 15 14:06:22
$GILD $ADXS $ FSLR $QIHU $INCY $ONCY $JNJG my favorates presently
$Stocknewsalerts
1 Apr 15 13:39:46
$INCY ALERT: New Incyte Corporation SEC Filing From our Stock News Alerts App
BNK Invest
1 Apr 15 13:38:48
Incyte Moves Up In Market Cap Rank, Passing Host Hotels & Resorts $INCY $HST #stocks http://t.co/NiJAMKeV5v
Media Sentiment
1 Apr 15 13:35:31
$INCY received a new alert. Find out why at http://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt #NYSE #NASDAQ #markets 342
BioRunUp
1 Apr 15 13:31:58
$INCY Officer and Treasurer CHARDONNET LAURENT Exercises & Sells $10.7M of INCY on 3/30/15
Insider Filings
1 Apr 15 13:30:06
$INCY: Chardonnet Laurent sold a net $8,764,688 in INCYTE CORP. http://t.co/ERyKYyQTM7
Insider Filings
1 Apr 15 13:29:25
$INCY: Huber Reid M sold a net $2,590,393 in INCYTE CORP. http://t.co/ERyKYyQTM7
StockNewsWires
1 Apr 15 13:29:02
$INCY: New Insider Transaction on INCY by EVP, Chief Scientific Officer: http://t.co/SR4KX9IFUF
Insider Alerts
1 Apr 15 13:28:09
NEW insider transaction on $INCY reported a moment ago: http://t.co/1BHCFRgmiI
Market Int Center
1 Apr 15 08:24:54
Potential Incyte $INCY Trade Has 9.27% Downside Protection ( http://t.co/pkA22BD9Bc )
Russell Barbour
31 Mar 15 22:19:31
Teenager who turned $9700 into more than $330,000 in less than 1 year!: http://t.co/aZExPEPZ0g $HOG $INCY $STJ $ISRG $SSO $OSIR
Penny Stock Secret
31 Mar 15 20:33:00
Premium Alerts Ranked #1 For Gains 2834% Last Week http://t.co/NovWYe2RAx .. $BOSC $INCY $SHLD
Capital Market Labs
31 Mar 15 15:35:30
$INCY vs. $ISIS vs. $BMRN vs. $PCYC Compared Across 9 Critical Measures Chart: http://t.co/2fEYdKDWoX
Ophir Gottlieb
31 Mar 15 15:34:07
$PCYC vs. $ALKS vs. $INCY vs. $MDVN Compared Across 9 Critical Measures Chart: http://t.co/qIa6Ne2E7m
Rachel Smith
31 Mar 15 06:17:18
$INCY - Why It's Not Too Late to Buy Agenus, Inc. Stock http://t.co/OSbg2smL9y
biotechnology smith
31 Mar 15 06:17:15
$INCY - Why It's Not Too Late to Buy Agenus, Inc. Stock http://t.co/65mIXI024Q
NASDAQ
31 Mar 15 06:17:12
$INCY - Why It's Not Too Late to Buy Agenus, Inc. Stock http://t.co/lnaZULHAmW
biotechnology smith
31 Mar 15 06:13:24
$INCY - Why It's Not Too Late to Buy Agenus, Inc. Stock http://t.co/2LbQ2aVxGD
NASDAQ
31 Mar 15 06:13:23
$INCY - Why It's Not Too Late to Buy Agenus, Inc. Stock http://t.co/9sX9qqMIRN
Rachel Smith
31 Mar 15 06:13:19
$INCY - Why It's Not Too Late to Buy Agenus, Inc. Stock http://t.co/QWYo18ThRo
Sleek Money
31 Mar 15 05:20:31
Incyte Rating Reiterated by Zacks $INCY http://t.co/msUSEghK5M
PennyStock Zone
30 Mar 15 23:25:12
Tip #4 How to identify a HOT trading SECTOR? http://t.co/WvpU6esv0n $MZOR $PNC $LBTYA $JOY $QTWO $TRN $ACXM $INCY
Daily Contracts
30 Mar 15 14:09:01
Real-Time feed of company contracts, original agreements and executive updates from $INCY http://t.co/KBicQORxY2
US Banking News
30 Mar 15 13:24:24
Incyte Earns “Hold” Rating from Zacks $INCY http://t.co/wY62IaGoI0
Ticker Report
30 Mar 15 13:10:19
Incyte Earns “Hold” Rating from Zacks $INCY http://t.co/UvJQ0THfMD
US Consumer News
30 Mar 15 13:00:36
Incyte's hold rating reiterated at Zacks. http://t.co/uYvOH1RDc9 $INCY #INCY
Analyst Ratings
30 Mar 15 12:55:34
Incyte's hold rating reiterated at Zacks. http://t.co/fiQzehsmuO $INCY #INCY
Phil I am Not
30 Mar 15 10:38:04
long $gern #hod $3.98 13% above 50 sma short $incy #imetelstat imo
NICK Poulopoulos
30 Mar 15 09:01:08
like $INCY for a bounce here
Breaking News Now
30 Mar 15 06:05:05
$XLNX $INCY $CAG $KRFT: 4 Buzzing Stocks: Xilinx Inc. (NASDAQ:XLNX), Incyte Corporation ...: http://t.co/Y1cmDz18uo
Capital Market Labs
30 Mar 15 01:22:33
$VRTX vs. $INCY vs. $BMRN vs. $REGN Compared Across 9 Critical Measures Chart: http://t.co/sYcGjc8frM
Sheff
30 Mar 15 00:22:33
$INCY..$94.36..Upcoming Milestones.. Will be an active participant at #ASCO2015 http://t.co/nmA5cRmGDT
biotech 2050
29 Mar 15 23:51:20
RT @JasonHolman5: $MRK - 11; $PCYC - 11; $IMGN - 11; $INCY - 10...& then there is $KPTI w/a whopping 21 sessions at AACR. Hats off to them!
ethan
29 Mar 15 22:32:54
RT @JasonHolman5: $MRK - 11; $PCYC - 11; $IMGN - 11; $INCY - 10...& then there is $KPTI w/a whopping 21 sessions at AACR. Hats off to them!
Michael
29 Mar 15 22:06:19
RT @JasonHolman5: $MRK - 11; $PCYC - 11; $IMGN - 11; $INCY - 10...& then there is $KPTI w/a whopping 21 sessions at AACR. Hats off to them!
christian balmaceda
29 Mar 15 18:21:01
RT @JasonHolman5: $MRK - 11; $PCYC - 11; $IMGN - 11; $INCY - 10...& then there is $KPTI w/a whopping 21 sessions at AACR. Hats off to them!
				
				
  +Follow August 21, 2013 9:20AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.